YASUSHI NAGATA

Last Updated :2020/08/03

Affiliations, Positions
Graduate School of Biomedical and Health Sciences(Medicine), Professor
E-mail
nagathiroshima-u.ac.jp

Basic Information

Major Professional Backgrounds

  • 2012/04/01, 2019/03/31, Hiroshima University, Institute of Biomedical & Health Sciences, Professor
  • 2015/10/01, Hiroshima High-Precision Radiotherapy Cancer Center, Director

Academic Degrees

  • Doctor of Philosophy in Medical Science, Kyoto University

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical internal medicine;Radiation science

Educational Activity

Course in Charge

  1. 2020, Undergraduate Education, First Semester, Radiation Biology & Radiation Health Risk Sciences
  2. 2020, Undergraduate Education, Year, Systemic Disease Control
  3. 2020, Undergraduate Education, Intensive, Practice for medical research
  4. 2020, Graduate Education (Doctoral Program) , First Semester, Principles of Oncology
  5. 2020, Graduate Education (Doctoral Program) , First Semester, Principles of Oncology
  6. 2020, Graduate Education (Doctoral Program) , First Semester, Principles of Oncology
  7. 2020, Graduate Education (Doctoral Program) , First Semester, Principles of Oncology
  8. 2020, Graduate Education (Doctoral Program) , First Semester, Advanced seminar on Radiation Oncology
  9. 2020, Graduate Education (Doctoral Program) , Second Semester, Advanced seminar on Radiation Oncology
  10. 2020, Graduate Education (Doctoral Program) , First Semester, Advanced seminar on Radiation Oncology
  11. 2020, Graduate Education (Doctoral Program) , Second Semester, Advanced seminar on Radiation Oncology
  12. 2020, Graduate Education (Doctoral Program) , First Semester, Advanced seminar on Multidisciplinary tumor board
  13. 2020, Graduate Education (Doctoral Program) , Second Semester, Advanced seminar on Multidisciplinary tumor board
  14. 2020, Graduate Education (Doctoral Program) , First Semester, Advanced research on Radiation Oncology
  15. 2020, Graduate Education (Doctoral Program) , Second Semester, Advanced research on Radiation Oncology
  16. 2020, Graduate Education (Doctoral Program) , First Semester, Practice of Oncology
  17. 2020, Graduate Education (Master's Program) , First Semester, Research on Radiation Oncology
  18. 2020, Graduate Education (Master's Program) , Second Semester, Research on Radiation Oncology
  19. 2020, Graduate Education (Master's Program) , First Semester, Physics of Diagnostic Radiology
  20. 2020, Graduate Education (Master's Program) , First Semester, Radiation Oncology Physics
  21. 2020, Graduate Education (Master's Program) , First Semester, Radiation Oncology
  22. 2020, Graduate Education (Master's Program) , Second Semester, Seminar on Radiation Oncology Physics
  23. 2020, Graduate Education (Master's Program) , Second Semester, Seminar on Radiation Dosimetry
  24. 2020, Graduate Education (Master's Program) , Second Semester, Seminar on Physics of Diagnostic Imaging
  25. 2020, Graduate Education (Master's Program) , First Semester, English for Scientific Paper
  26. 2020, Graduate Education (Master's Program) , Second Semester, Health Physics
  27. 2020, Graduate Education (Doctoral Program) , 1Term, Principles of Oncology
  28. 2020, Graduate Education (Doctoral Program) , 1Term, Practice of Oncology
  29. 2020, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Radiation Oncology
  30. 2020, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Radiation Oncology
  31. 2020, Graduate Education (Doctoral Program) , First Semester, Advanced Research on Radiation Oncology
  32. 2020, Graduate Education (Doctoral Program) , Second Semester, Advanced Research on Radiation Oncology
  33. 2020, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Radiation Oncology
  34. 2020, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Radiation Oncology
  35. 2020, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Multidisciplinary Tumor Board

Research Activities

Academic Papers

  1. Preliminary Report of Late Recurrences, at 5 Years or More, after Stereotactic Body Radiation Therapy for Non-small Cell Lung Cancer, JOURNAL OF THORACIC ONCOLOGY, 7(2), 453-456, FEB 2012
  2. Functional Image-Guided Radiotherapy Planning in Respiratory-Gated Intensity-Modulated Radiotherapy for Lung Cancer Patients With Chronic Obstructive Pulmonary Disease, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 82(4), E663-E670, MAR 15 2012
  3. Dose-Volume Metrics Associated With Radiation Pneumonitis After Stereotactic Body Radiation Therapy for Lung Cancer, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 83(4), E545-E549, JUL 15 2012
  4. Long-term outcomes of intraluminal brachytherapy in combination with external beam radiotherapy for superficial esophageal cancer, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 17(3), 263-271, JUN 2012
  5. Treatment Outcome of Medium-Dose-Rate Intracavitary Brachytherapy for Carcinoma of the Uterine Cervix: Comparison With Low-Dose-Rate Intracavitary Brachytherapy, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 84(1), 137-145, SEP 1 2012
  6. Detailed dosimetric evaluation of intensity-modulated radiation therapy plans created for stage C prostate cancer based on a planning protocol, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 17(5), 505-511, OCT 2012
  7. Coronary Artery Calcium Scoring on Different 64-detector Scanners Using a Low-tube Voltage (80 kVp), ACADEMIC RADIOLOGY, 19(11), 1402-1407, NOV 2012
  8. Time-dependent cell disintegration kinetics in lung tumors after irradiation., Physics in medicine and biology, 53(9), 2413-1423, 20080401
  9. Japanese structure survey of radiaiton oncology in 2005 based on institutional stratification of patterns of care study., International journal of radiaiton oncology biology physics, 72(1), 144-152, 20080901
  10. National structure of radiation oncology in Japan with special reference to desighnated cancer care hospitals, International journal of clinical oncology, 14(3), 244-247, 20090601
  11. Effect of audio coaching on correlation of abdominal displacement with lung tumor motion., Int J Radiat Oncol Biol Phys, 75(2), 558-563, 20091001
  12. Intra-arterial infusion chemotherapy using cisplatin with radiotherapy for Stage III squamous cell carcinoma of the cervix., Int J Radiat Oncol Biol Phys, 75(2), 369-377, 20091001
  13. Radiation therapy for esophageal cancer in Japan: results of the Patterns of Care Study 1999-2001., Int J Radiat Oncol Biol Phys., 75(2), 357-363, 20091001
  14. Survey of stereotactic body radiation therapy in Japan by the Japan 3-D Conformal External Beam Radiotherapy Group, Int J Radiat Oncol Biol Phys, 75(2), 343-347, 20091001
  15. Results of a preliminary study using hypofractionated involved field radiation therapy and concurrent carboplatin/paclitaxel in the treatment of locally advanced Non-Small-Cell lung cancer, Int J Clin Oncol,, 14(5), 408-415, 20091001
  16. Clinical Outcomes of Stereotactic Body Radiotherapy for Small Lung Lesions Clinically Diagnosed as Primary Lung Cancer on Radiologic Examination, Int J Radiat Oncol Biol Phys, 75(3), 683-687, 20091101
  17. Stereotactic Body Radiation Therapy for Early Non-Small Cell Lung Cancer., Front Radiat Ther Oncol, 42, 94-114, 20100101
  18. Prognostic Factors in Stereotactic Body Radiotherapy for Non-Small-Cell Lung Cancer., International Journal of Radiation Oncology= Biology= Physics, 79(4), 1104-1111, 20110301
  19. Radiation pneumonitis in patients with lung and mediastinal tumours: a retrospective study of risk factors focused on pulmonary emphysema., The British Journal of Radiology, 85(1010), 135-141, 20110201
  20. Characterization of FDG-PET images after stereotactic body radiation therapy for lung cancer, 97(2), 200-204, 20110401
  21. Detailed dosimetric evaluation of intensity-modulated radiation therapy plans created for stage C prostate cancer based on a planning protocol., International journal of clinical oncology, 20110901
  22. Stereotactic body radiotherapy (SBRT) for operable stage I non–small-cell lung cancer: Can SBRT be comparable to surgery?, International Journal of Radiation Oncology= Biology= Physics, 81(5), 1352-1358, 20111201
  23. Six-year experience of permanent prostate brachytherapy for clinically localized prostate cancer., Hiroshima Journal of Medical Science, 60(4), 51-56, 20111201
  24. In reply to Drs. Atalar, Caglar, and Ozyar, International Journal of Radiation Oncology= Biology= Physics, 82(2), 521, 20120201
  25. Geometrical differences in target volumes between slow CT and 4D CT imaging in stereotactic body radiotherapy for lung tumors in the upper and middle lobe, MEDICAL PHYSICS, 35(9), 4142-4148, SEP 2008
  26. National structure of radiation oncology in Japan with special reference to designated cancer care hospitals, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 14(3), 237-244, JUN 2009
  27. SURVEY OF STEREOTACTIC BODY RADIATION THERAPY IN JAPAN BY THE JAPAN 3-D CONFORMAL EXTERNAL BEAM RADIOTHERAPY GROUP, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 75(2), 343-347, OCT 1 2009
  28. RADIATION THERAPY FOR ESOPHAGEAL CANCER IN JAPAN: RESULTS OF THE PATTERNS OF CARE STUDY 1999-2001, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 75(2), 357-363, OCT 1 2009
  29. EFFECT OF AUDIO COACHING ON CORRELATION OF ABDOMINAL DISPLACEMENT WITH LUNG TUMOR MOTION, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 75(2), 558-563, OCT 1 2009
  30. CLINICAL OUTCOMES OF STEREOTACTIC BODY RADIOTHERAPY FOR SMALL LUNG LESIONS CLINICALLY DIAGNOSED AS PRIMARY LUNG CANCER ON RADIOLOGIC EXAMINATION, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 75(3), 683-687, NOV 1 2009
  31. Results of a preliminary study using hypofractionated involved-field radiation therapy and concurrent carboplatin/paclitaxel in the treatment of locally advanced non-small-cell lung cancer, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 14(5), 408-415, OCT 2009
  32. Impact of multileaf collimator width on intraprostatic dose painting plans for dominant intraprostatic lesion of prostate cancer, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 11(4), 144-154, 2010
  33. Characterization of FDG-PET images after stereotactic body radiation therapy for lung cancer, RADIOTHERAPY AND ONCOLOGY, 97(2), 200-204, NOV 2010
  34. STEREOTACTIC RADIOTHERAPY OF PRIMARY LUNG CANCER AND OTHER TARGETS: RESULTS OF CONSULTANT MEETING OF THE INTERNATIONAL ATOMIC ENERGY AGENCY, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 79(3), 660-669, MAR 1 2011
  35. PROGNOSTIC FACTORS IN STEREOTACTIC BODY RADIOTHERAPY FOR NON-SMALL-CELL LUNG CANCER, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 79(4), 1104-1111, MAR 15 2011
  36. Clinical outcome of esophageal varices after hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with major portal vein tumor thrombus, HEPATOLOGY RESEARCH, 41(11), 1046-1056, NOV 2011
  37. STEREOTACTIC BODY RADIOTHERAPY (SBRT) FOR OPERABLE STAGE I NON SMALL-CELL LUNG CANCER: CAN SBRT BE COMPARABLE TO SURGERY?, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 81(5), 1352-1358, DEC 1 2011
  38. Radiation pneumonitis in patients with lung and mediastinal tumours: a retrospective study of risk factors focused on pulmonary emphysema, BRITISH JOURNAL OF RADIOLOGY, 85(1010), 135-141, FEB 2012
  39. Hepatic arterial infusion chemotherapy using 5-fluorouracil and systemic interferon-a for advanced hepatocellular carcinoma in combination with or without three-dimensional conformal radiotherapy to venous tumor thrombosis in hepatic vein or inferior vena cava, HEPATOLOGY RESEARCH, 42(5), 442-453, MAY 2012
  40. Dynamic computed tomography appearance of tumor response after stereotactic body radiation therapy for hepatocellular carcinoma: How should we evaluate treatment effects?, HEPATOLOGY RESEARCH, 43(7), 717-727, JUL 2013
  41. Stereotactic body radiation therapy combined with transcatheter arterial chemoembolization for small hepatocellular carcinoma, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 28(3), 530-536, MAR 2013
  42. Stereotactic Body Radiotherapy for Early Stage Lung Cancer, CANCER RESEARCH AND TREATMENT, 45(3), 155-161, SEP 2013
  43. Effectiveness of Cervical Cancer Screening Based on a Mathematical Screening Model using data from the Hiroshima Prefecture Cancer Registry, ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 14(8), 4897-4902, 2013
  44. Pilot Study of Stereotactic Body Radiation Therapy Combined with Transcatheter Arterial Chemoembolization for Small Hepatocellular Carcinoma, HEPATO-GASTROENTEROLOGY, 61(129), 31-36, JAN-FEB 2014
  45. Reorganization of Damaged Chromatin by the Exchange of Histone Variant H2A.Z-2, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 89(4), 736-744, JUL 15 2014
  46. Safety and effectiveness of stereotactic body radiotherapy for a clinically diagnosed primary stage I lung cancer without pathological confirmation, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 19(5), 814-821, OCT 2014
  47. Time-Adjusted Internal Target Volume: A Novel Approach Focusing on Heterogeneity of Tumor Motion Based on 4-Dimensional Computed Tomography Imaging for Radiation Therapy Planning of Lung Cancer, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 89(5), 1129-1137, AUG 1 2014
  48. Case reports of portal vein thrombosis and bile duct stenosis after stereotactic body radiation therapy for hepatocellular carcinoma, HEPATOLOGY RESEARCH, 44(10), E273-E278, OCT 2014
  49. Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: A propensity score matching analysis, EUROPEAN JOURNAL OF CANCER, 50(17), 2932-2938, NOV 2014
  50. Video-Assisted Thoracoscopic Lobectomy Versus Stereotactic Radiotherapy for Stage I Lung Cancer, ANNALS OF THORACIC SURGERY, 99(4), 1122-1129, MAR 27 2015
  51. Clinical experience of volumetric modulated arc therapy for malignant pleural mesothelioma after extrapleural pneumonectomy, JOURNAL OF RADIATION RESEARCH, 56(2), 315-324, MAR 2015
  52. Stereotactic body radiotherapy for patients with small hepatocellular carcinoma ineligible for resection or ablation therapies, HEPATOLOGY RESEARCH, 45(4), 378-386, APR 2015
  53. Role of 3-D conformal radiotherapy for major portal vein tumor thrombosis combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma, HEPATOLOGY RESEARCH, 45(6), 607-617, JUN 2015
  54. The Time Course of Dynamic Computed Tomographic Appearance of Radiation Injury to the Cirrhotic Liver Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma, PLOS ONE, 10(6), e0125231, JUN 11 2015
  55. Results of sequential chemoradiotherapy for intracranial germinoma, JAPANESE JOURNAL OF RADIOLOGY, 33(6), 336-343, JUN 2015
  56. Results of Neoadjuvant Chemoradiotherapy With Docetaxel and 5-Fluorouracil Followed by Esophagectomy to Treat Locally Advanced Esophageal Cancer, ANNALS OF THORACIC SURGERY, 99(6), 1887-1893, JUN 2015
  57. Stereotactic body radiotherapy, 名 Japanese Journal of Cancer and Chemotherapy, 41(13), 2543-2545, 2014.12
  58. Radiation-induced pyogenic vertebral osteomyelitis after re-irradiation for para-aortic lymph node metastases in a patient with cervical cancer, International Cancer Conference Journal, 3(4), 207-210, 2014.10
  59. Time-adjusted internal target volume: a novel approach focusing on heterogeneity of tumor motion based on 4-dimensional computed tomography imaging for radiation therapy planning of lung cancer., Int J Radiat Oncol Biol Phys, 89(5), 1129-1137, 2014.8
  60. Reorganization of damaged chromatin by the exchange of histone variant H2A.Z-2., Int J Radiat Oncol Biol Phys., 89(4), 736-744, 2014.7
  61. Long-term results of definitive concurrent chemoradiotherapy for patients with esophageal submucosal cancer (T1bN0M0), INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 20(5), 897-904, OCT 2015
  62. The development of stereotactic body radiotherapy in the past decade: a global perspective, FUTURE ONCOLOGY, 11(19), 2721-2733, 2015
  63. Clinical utility of gadoxetate disodium-enhanced hepatic MRI for stereotactic body radiotherapy of hepatocellular carcinoma, JAPANESE JOURNAL OF RADIOLOGY, 33(10), 627-635, OCT 2015
  64. Combined Ventilation and Perfusion Imaging Correlates With the Dosimetric Parameters of Radiation Pneumonitis in Radiation Therapy Planning for Lung Cancer, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 93(4), 778-787, NOV 15 2015
  65. Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 93(5), 989-996, DEC 1 2015
  66. Cerebral blood flow in transient hypothyroidism after thyroidectomy: Arterial spin labeling magnetic resonance study, NEUROENDOCRINOLOGY LETTERS, 36(6), 545-551, 2015
  67. Evaluation of adverse events in atomic bomb survivors receiving curative-intent radiation therapy from 2005 to 2010, RADIOTHERAPY AND ONCOLOGY, 118(1), 60-64, 201601
  68. Availability of applying diaphragm matching with the breath-holding technique in stereotactic body radiation therapy for liver tumors, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 32(4), 557-561, APR 2016
  69. Long-term results after 12-year follow-up of patients treated with whole-breast and boost irradiation after breast-conserving surgery, JAPANESE JOURNAL OF RADIOLOGY, 34(9), 595-604, SEP 2016
  70. Simple quality assurance method of dynamic tumor tracking with the gimbaled linac system using a light field, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 17(5), 177-183, 2016
  71. Lipiodol impact on dose distribution in liver SBRT after TACE, Medeical Physics, 42(2), 3212-3212, 2015.6
  72. Treatment outcomes of patients with FIGO Stage I/II uterine cervical cancer treated with definitive radiotherapy: a multi-institutional retrospective research study., J Radiat Res, 56(5), 841-848, 201509
  73. Role of definitive chemoradiotherapy using docetaxel and 5-fluorouracil in patients with unresectable locally advanced esophageal squamous cell carcinoma: a phase II study., Diseases of the Esophagus, 2015
  74. Clinical outcomes of radiotherapy for esophageal cancer between 2004 and 2008: the second survey of the Japanese Radiation Oncology Study Group (JROSG)., Int J Clin Oncol, 21(1), 88-94, 2016.2
  75. Stereotactic body radiotherapy versus lobectomy for operable clinical stage IA lung adenocarcinoma: comparison of survival outcomes in two clinical trials with propensity score analysis (JCOG1313-A), JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 46(8), 748-753, AUG 2016
  76. Gafchromic EBT-XD film: Dosimetry characterization in high-dose, volumetric-modulated arc therapy, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 17(6), 312-322, 2016
  77. Role of definitive chemoradiotherapy using docetaxel and 5-fluorouracil in patients with unresectable locally advanced esophageal squamous cell carcinoma: a phase II study, DISEASES OF THE ESOPHAGUS, 29(8), 1115-1120, NOV-DEC 2016
  78. Method of evaluating respiratory induced organ motion by vector volume histogram, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 32(12), 1570-1574, DEC 2016
  79. Absorbed dose and image quality of Varian TrueBeam CBCT compared with OBI CBCT, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 32(12), 1628-1633, DEC 2016
  80. Quality assurance of a gimbaled head swing verification using feature point tracking, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 18(1), 49-52, JAN 2017
  81. Marginal prescription equivalent to the isocenter prescription in lung stereotactic body radiotherapy: preliminary study for Japan Clinical Oncology Group trial (JCOG1408), JOURNAL OF RADIATION RESEARCH, 58(1), 149-154, JAN 2017
  82. Dosimetric impact of Lipiodol in stereotactic body radiation therapy on liver after trans-arterial chemoembolization, MEDICAL PHYSICS, 44(1), 342-348, JAN 2017
  83. A randomized Phase III trial of comparing two dose-fractionations stereotactic body radiotherapy (SBRT) for medically inoperable Stage IA non-small cell lung cancer or small lung lesions clinically diagnosed as primary lung cancer: Japan Clinical Oncology Group Study JCOG1408 (J-SBRT trial), JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 47(3), 277-281, MAR 2017
  84. Dose Escalation Improves Outcome in Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Colorectal Cancer, ANTICANCER RESEARCH, 37(5), 2709-2713, MAY 2017
  85. Functional image-guided stereotactic body radiation therapy planning for patients with hepatocellular carcinoma, MEDICAL DOSIMETRY, 42(2), 97-103, SUM 2017
  86. Accidental overexposure related to new radiation therapy technologies, JOURNAL OF RADIATION ONCOLOGY, 6(2), 117-132, JUN 2017
  87. Evaluation of beam modeling for small fields using a flattening filter-free beam, RADIOLOGICAL PHYSICS AND TECHNOLOGY, 10(1), 33-40, MAR 2017
  88. Quality assurance for dynamic tumor tracking using the Vero4DRT system, International Journal of Cancer Therapy and Oncology, 4(1), 49-52, 2016
  89. Impact of reduction of flux overlap region on kilovoltage cone-beam computed tomography image quality and patients’ exposure dose., Rep Pract Oncol Radiother, 21(5), 460-465, AUG 2016
  90. Availability of applying diaphragm matching with the breath-holding technique in stereotactic body radiation therapy for liver tumors., Phys Med., 32(4), 557-561, APR 2016
  91. Dataset for Beam Commissioning of the Vero4DRT System,, International Journal of Medical Physics, Clinical Engineering and Radiation Oncology, 70-77, MAY 2016
  92. Hepatectomy after down-staging of hepatocellular carcinoma with portal vein tumor thrombus using chemoradiotherapy: A retrospective cohort study., Int J Surg, 44, 223-228, AUG 2017
  93. Efficacy of robust optimization plan with partial-arc VMAT for photon volumetric-modulated arc therapy: A phantom study., J Appl Clin Med Phys, Epub ahead of print, 2017
  94. Evaluation of cone-beam computed tomography image quality assurance for Vero4DRT system., Rep Pract Oncol Radiother, 22(3), 258-263, May-Jun 2017
  95. Clinical outcomes of stereotactic body radiotherapy for elderly patients with hepatocellular carcinoma., Hepatol Res, Epub ahead of print, 2017
  96. Phase I study of stereotactic body radiation therapy for centrally located stage IA non-small cell lung cancer (JROSG10-1)., Int J Clin Oncol., Epub ahead of print, 2017
  97. Effect of tumor amplitude and frequency on 4D modeling of Vero4DRT system., Reports of practical oncology and radiotherapy, 22(4), 290-304, 2017
  98. In Regard to Nagata et al., Int J Radiat Oncol Biol Phys., 96(4), 1320-1320, JUL 2016
  99. Impact of reduction of flux overlap region on kilovoltage cone-beam computed tomography image quality and patients' exposure dose., Rep Pract Oncol Radiother, 21(5), 460-465, SEP-OCT 2016
  100. Hepatectomy after down-staging of hepatocellular carcinoma with portal vein tumor thrombus using chemoradiotherapy: A retrospective cohort study, INTERNATIONAL JOURNAL OF SURGERY, 44, 223-228, AUG 2017
  101. Evaluation of cone-beam computed tomography image quality assurance for Vero4DRT system, REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 22(3), 258-263, MAY-JUN 2017
  102. Effect of tumor amplitude and frequency on 4D modeling of Vero4DRT system, REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 22(4), 290-294, JUL-AUG 2017
  103. Split-VMAT technique to control the expiratory breath-hold time in liver stereotactic body radiation therapy, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 40, 17-23, AUG 2017
  104. Phase I study of stereotactic body radiation therapy for centrally located stage IA non-small cell lung cancer (JROSG10-1), INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 22(5), 849-856, OCT 2017
  105. Clinical outcomes of concurrent chemoradiotherapy with volumetric modulated arc therapy in patients with locally advanced nasopharyngeal carcinoma, JAPANESE JOURNAL OF RADIOLOGY, 35(11), 673-680, NOV 2017
  106. Efficacy of robust optimization plan with partial-arc VMAT for photon volumetric-modulated arc therapy: A phantom study, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 18(5), 97-103, SEP 2017
  107. Impact of deformable image registration accuracy on thoracic images with different regularization weight parameter settings, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 42, 108-111, OCT 2017
  108. Proposed patient motion monitoring system using feature point tracking with a web camera, AUSTRALASIAN PHYSICAL & ENGINEERING SCIENCES IN MEDICINE, 40(4), 939-942, DEC 2017
  109. Accuracy of the raw-data-based effective atomic numbers and monochromatic CT numbers for contrast medium with a dual-energy CT technique, BRITISH JOURNAL OF RADIOLOGY, 91(1082), 2018
  110. Clinical outcomes of stereotactic body radiotherapy for elderly patients with hepatocellular carcinoma, HEPATOLOGY RESEARCH, 48(2), 193-204, FEB 2018
  111. A Chemical Modulator of p53 Transactivation that Acts as a Radioprotective Agonist, MOLECULAR CANCER THERAPEUTICS, 17(2), 432-442, FEB 2018
  112. Energy spectrum and dose enhancement due to the depth of the Lipiodol position using flattened and unflattened beams, REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 23(1), 50-56, JAN-FEB 2018
  113. Effect of secondary electron generation on dose enhancement in Lipiodol with and without a flattening filter, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 19(2), 211-217, MAR 2018
  114. Interfractional diaphragm changes during breath-holding in stereotactic body radiotherapy for liver cancer, REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 23(2), 84-90, MAR-APR 2018
  115. Tolerance levels of CT number to electron density table for photon beam in radiotherapy treatment planning system, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 19(1), 271-275, JAN 2018
  116. Relative biological effectiveness study of Lipiodol based on microdosimetric-kinetic model, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 46, 89-95, FEB 2018
  117. Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy Combined with Radiotherapy and Sorafenib for Advanced Hepatocellular Carcinoma Patients with Major Portal Vein Tumor Thrombosis, ONCOLOGY, 94(4), 215-222, 2018
  118. Evaluation of Prognostic Factors for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery, WORLD JOURNAL OF SURGERY, 42(5), 1496-1505, MAY 2018
  119. Stereotactic body radiotherapy (SBRT) for Stage I lung cancer, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 48(5), 405-409, MAY 2018
  120. Results of a multi-institutional, randomized, non-inferiority, phase III trial of accelerated fractionation versus standard fractionation in radiation therapy for T1-2N0M0 glottic cancer: Japan Clinical Oncology Group Study JCOG0701), ANNALS OF ONCOLOGY, 29(4), 992-997, APR 2018
  121. 4D modeling in a gimbaled linear accelerator by using gold anchor markers, REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 23(3), 183-188, MAY-JUN 2018
  122. Impact of reduction of flux overlap region on kilovoltage cone-beam computed tomography image quality and patients' exposure dose, REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 21(5), 460-465, SEP-OCT 2016
  123. Image quality and absorbed dose comparison of single- and dual-source cone-beam computed tomography, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 19(3), 360-366, MAY 2018
  124. A novel verification method using a plastic scintillator imagining system for assessment of gantry sag in radiotherapy, MEDICAL PHYSICS, 45(6), 2411-2424, JUN 2018
  125. Quantifying esophageal motion during free-breathing and breath-hold using fiducial markers in patients with early-stage esophageal cancer, PLOS ONE, 13(6), JUN 11 2018
  126. Preoperative prediction of a pathologic complete response of esophageal squamous cell carcinoma to neoadjuvant chemoradiotherapy, SURGERY, 164(1), 40-48, JUL 2018
  127. Long-term outcome of stereotactic body radiotherapy for patients with small hepatocellular carcinoma, HEPATOLOGY RESEARCH, 48(9), 701-707, AUG 2018
  128. Stereotactic body radiotherapy to treat small lung lesions clinically diagnosed as primary lung cancer by radiological examination: A prospective observational study, LUNG CANCER, 122, 107-112, AUG 2018
  129. Hepatectomy versus stereotactic body radiotherapy for primary early hepatocellular carcinoma: A propensity-matched analysis in a single institution, SURGERY, 164(2), 219-226, AUG 2018
  130. Automatic contrast medium extraction system using electron density data with dual-energy CT, BRITISH JOURNAL OF RADIOLOGY, 91(1090), 2018
  131. Comparison of Stereotactic Body Radiation Therapy Combined With or Without Transcatheter Arterial Chemoembolization for Patients With Small Hepatocellular Carcinoma Ineligible for Resection or Ablation Therapies, TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 17, JUL 1 2018
  132. Evaluation of optimization workflow using design of experiment (DoE) for various field configurations in volumetric-modulated arc therapy, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 54, 34-41, 201810
  133. Clinical features of prostate-specific antigen bounce after I-125 brachytherapy for prostate cancer, JOURNAL OF RADIATION RESEARCH, 59(5), 649-655, 201809
  134. Long-term results of neoadjuvant chemoradiotherapy using cisplatin and 5-fluorouracil followed by esophagectomy for resectable, locally advanced esophageal squamous cell carcinoma, JOURNAL OF RADIATION RESEARCH, 59(5), 616-624, 201809
  135. Gantry angle classification with a fluence map in intensity-modulated radiotherapy for prostate cases using machine learning, POLISH JOURNAL OF MEDICAL PHYSICS AND ENGINEERING, 24(4), 165-169, 201812
  136. Development of geometrically ideal dose distribution as a reference for treatment planning in VMAT using filtered back-projection method, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 57, 115-122, 201901
  137. Predictive gamma passing rate by dose uncertainty potential accumulation model, MEDICAL PHYSICS, 46(2), 999-1005, 201902
  138. Volumetric modulated arc therapy with robust optimization for larynx cancer, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 58, 54-58, 201902
  139. A novel risk analysis of clinical reference dosimetry based on failure modes and effects analysis, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 58, 59-65, 201902
  140. Early Recurrence and Cancer Death After Trimodal Therapy for Esophageal Squamous Cell Carcinoma, ANTICANCER RESEARCH, 39(3), 1433-1440, 201903
  141. Effect of image quality on correlation modeling error using a fiducial marker in a gimbaled linear accelerator, REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 24(2), 233-238, 2019
  142. Automatic calibration of an arbitrarily-set near-infrared camera for patient surface respiratory monitoring, MEDICAL PHYSICS, 46(3), 1163-1174, 201903
  143. How to Improve the Conspicuity of Breast Tumors on Computed High b-value Diffusion-weighted Imaging, MAGNETIC RESONANCE IN MEDICAL SCIENCES, 18(2), 119-125, 2019
  144. A primary analysis of a multicenter, prospective, single-arm, confirmatory trial of hypofractionated whole breast irradiation after breast-conserving surgery in Japan: JCOG0906, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 49(1), 57-62, 201901
  145. Concurrent chemoradiotherapy for locally advanced squamous cell carcinoma of the cervix in a uterus didelphys with vaginal septum, JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 11(2), 180-188, 2019
  146. Clinical Significance of F-18-Fluorodeoxyglucose-Positron Emission Tomography-Positive Lymph Nodes to Outcomes of Trimodal Therapy for Esophageal Squamous Cell Carcinoma, ANNALS OF SURGICAL ONCOLOGY, 26(6), 1869-1878, 201906
  147. Investigation of the applicability of the ESR nail dosimetry for assessment of accidental exposure in medical facilities, RADIATION MEASUREMENTS, 124, 91-97, 201905
  148. Tolerance levels of mass density for CT number calibration in photon radiation therapy, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 20(6), 45-52, 201906
  149. Photon and electron backscatter dose and energy spectrum analysis around Lipiodol using flattened and unflattened beams, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 20(6), 178-183, 201906
  150. Automatic gas detection in prostate cancer patients during image-guided radiation therapy using a deep convolutional neural network, Physica Medica, 64, 24-28, 2019
  151. 放射線科医の魅力とリクルート 放射線治療医編, 臨床画像, 34(7), 889-891, 201807

Publications such as books

  1. 2015/.8/.1, Stereotactic Body Radiation Therapy, Springer Japan, 2015, 8, English, Yasushi Nagata, 254

Invited Lecture, Oral Presentation, Poster Presentation

  1. Stereotactic body radiotherapy for early stage lung cancer., Yasushi Nagata, The 3rd International Medical Symposium of Dong-A University., 2014/02/07, With Invitation, Dong-A University., Busan, Korea.
  2. SBRT for lung cancer in Japan, Yasushi Nagata, HICARE/IAEA International Training Course. 2015.1.19-22. Hiroshima., With Invitation, HICARE, Hiroshima, Japan
  3. Current status of Stereotatic Body Radiation Therapy (SBRT) in Japan., Yasushi Nagata, 15th International Congress of Radiation Research, 2015/05/25, Without Invitation, International Congress of Radiation Research, Kyoto, Japan
  4. Evaluation of Beam Modeling for Small Field using Flattening Filter Free, Daisuke Kawahara, The 15th International congress of Radiation Research(ICRR), 2015/05/25, Without Invitation, International congress of Radiation Research, Kyoto, Japan
  5. Gd-EOB-DTPA enhanced MRI guided stereotactic body radiation therapy planning for patients with hepatocellular carcinoma., Tsegmed U, Kimura T, Nakashima T, Nakamura Y, Higaki T, Imano N, Doi Y, Kenjo M, Ozawa S, Murakami Y, Awai K, Nagata Y., Proceedings of the American Society for Radiation Oncology 57th annual meeting(ASTRO), 2015/10/18, Without Invitation, American Society for Radiation Oncology, San Antonio,Texas, USA
  6. Dosimetric comparison between volumetric modulated arc therapy and conventional 3D conformal radiotherapy for middle thoracic esophageal cancer., Doi Y, Murakami Y., Kawabata H., Takeuchi Y., Nishibuchi I.,Okabe T., Kenjo M., Kimura T., Nagata Y., 2015/11/19, Without Invitation
  7. Current Status of Stereotactic Body Radiation Therapy (SBRT) in Japan, Nagata Yasushi, GAP (Global Academic Program) related Meeting between Hiroshima University and The University of Texas MD Anderson Cancer Center, 2016/07/22, With Invitation, Hiroshima University and The University of Texas MD Anderson Cancer Center, Hiroshima city
  8. The use of diagnostic imging on Liver Cancer., Yaushi Nagata, 34th Annual Meeting of Korean Society for Radiation Oncology, 2016/10/14, With Invitation, Korean Society for Radiation Oncology, Seoul Korea
  9. Current status of stereotactic body radiation therapy (SBRT) in Japan., Yasushi Nagata, IASLC 17th World Conference on Lung Cancer, 2016/12/04, Without Invitation, IASLC, Vienna, Austria
  10. Analysis of DEF and energy spectrum with PHITS on Lipiodol using the flattened and unflattened photon beams., 2016/09/08, Without Invitation
  11. Combined ventilationand perfusion imaging correlates with the dosimetric parameters of radiatoin pneumonitis in radiation therapy planning for lung cancer., T. Kimura, T. Nakashima, A. Saito, Y. Takeuchi, I. Takahashi, I. Nishibuchi, Y. Murakami, T. Nishio, Y. Nagata., Proceedings of the American Society for Radiation Oncology 57th annual meeting(ASTRO), 2016/09/25, Without Invitation, American Society for Radiation Oncology, Boston, MA, USA
  12. A simplified Three-Isocenter IMRT for craniospinal irradiation to minimize planning and treatment time, I. Takahashi, K. Kashiwado, Y. Takeuchi, I. Nishibuchi, A. Saito, T. Kimura, Y. Murakami, Y. Nagata, Proceedings of the American Society for Radiation Oncology 57th annual meeting(ASTRO), 2016/09/25, Without Invitation, American Society for Radiation Oncology, Boston, MA, USA
  13. Verification of mechanical and dosimetric accuracy for head and neck volumetric modulated arc therapy with jaw tracking, T. Okumura, T. Nakashima, M. Aita, Y. Ochi, D. Kawahara, H. Masuda, K. Hioki, Y. Ohno, A. Saito, Y. Nagata, Proceedings of the American Society for Radiation Oncology 57th annual meeting(ASTRO), 2016/09/25, Without Invitation, American Society for Radiation Oncology, Boston, MA, USA
  14. Salvage radiotherapy for superficial esophageal cancer after incomplete endoscopic resection, I. Nishibuchi, Y. Murakami, I. Takahashi, Y. Takeuchi, A. Saito, T. Kimura, T. Nishio, Y. Nagata, Proceedings of the American Society for Radiation Oncology 57th annual meeting(ASTRO), 2016/09/25, Without Invitation, American Society for Radiation Oncology, Boston, MA, USA
  15. Impact of expiratory tumor motion patterns on dose volume histogram in treatment phase selection of respiratory gating radiation therapy for lung cancer, N. Imano, I. Nishibuchi, T. Kimura, T. Nakashima, T. Okumura, Y. Murakami, Y. Nagata, Proceedings of the American Society for Radiation Oncology 57th annual meeting(ASTRO), 2016/09/25, Without Invitation, American Society for Radiation Oncology, Boston, MA, USA
  16. Kompeito-Shot: Development of a Novel Verification System for 3D Beam Alignment Including the Sag of Gantry Head, M Tsuneda, T Nishio , A Saito, K Hioki , D Kawahara, Y Ochi, K Matsushita, S Tanaka, S Ozawa, Y Nagata, AAPM2016(the American Association of Physicists in Medicine), 2016/07/31, Without Invitation, the American Association of Physicists in Medicine, Washington, USA
  17. Energy Spectral Study On Lipiodol After Trans-Arterial Chemoembolization Using the Flattened and Unflattened Photon Beams, D Kawahara, S Ozawa, A Saito, T Nishio, K Hioki , H Masuda , T Okumura , Y Ochi , T Nakashima , T Suzuki, S Tanaka,Y Ohno, Y Nagata, AAPM2016(the American Association of Physicists in Medicine), 2016/07/31, Without Invitation, the American Association of Physicists in Medicine, Washington, USA
  18. Stereotactic body radiotherapy for patients with small hepatocellular carcinoma ineligible for ablation therapies., T. Kimura, H. Aikata, I. Takahashi, Y. Takeuchi, I. Nishibuchi, Y. Murakami, K. Awai, K. Chayama, Y. Nagata, GAP (Global Academic Program) related Meeting between Hiroshima University and The University of Texas MD Anderson Cancer Center, 2016/07/22, Without Invitation, Hiroshima University and The University of Texas MD Anderson Cancer Center, Hiroshima city
  19. Evaluation of adverse events in Atomic Bomb survivors receiving curative-intent radiation therapy from 2005 to 2010, Y. Doi, Y. Murakami, M. Kenjo, T. Kimura, Y. Nagata, GAP (Global Academic Program) related Meeting between Hiroshima University and The University of Texas MD Anderson Cancer Center, 2016/07/22, Without Invitation, Hiroshima University and The University of Texas MD Anderson Cancer Center, Hiroshima Japan
  20. Clinical features of metachronous cancer in patients with esophageal cancer treated by definitive radiation therapy, Y. Murakami, Y. Takeuchi, I. Takahashi, I. Nishibuchi, T. Kimura, Y. Nagata, GAP (Global Academic Program) related Meeting between Hiroshima University and The University of Texas MD Anderson Cancer Center, 2016/07/22, Without Invitation, Hiroshima University and The University of Texas MD Anderson Cancer Center, Hiroshima Japan
  21. Impact of inflammation and sarcopenia on outcomes after stereotactic body radiotherapy for T1N0M0 non-small cell lung cancer., Matsuo Y, Nagata Y, Wakabayashi M, Eba J, Ishikura S, Onishi H, Kokubo M, Karasawa K, Shioyama Y, Onimaru R, Hiraoka M., IASLC 17th World Conference on Lung Cancer, 2016/12/04, Without Invitation, IASLC, Vienna, Austria
  22. Treatment results of definitive chemo-radiation therapy in patients with cervical esophageal cancer., Y. Takeuchi, Y. Murakami, I. Takahashi, I. Nishibuchi, T. Kimura, A. Saito, T. Nishio, Y. Nagata., 2016/11/25, Without Invitation
  23. Published clinical trials in Japan, JCOG0403, Nagata Y, 2017 Trilateral Symposium, 2017/12/09, With Invitation, Shenzhen, China.
  24. Ongoing clinical trials in Japan, JCOG1408, Nagata Y, 2017 Trilateral Symposium, 2017/12/09, Without Invitation, Shenzhen, China.
  25. Simulation study of volumetric modulated arc therapy for thoracic esophageal cancer using automated-radiotherapy planning software., Murakami Y,Nagata Y,Kimura T,Nishibuchi I,Nakashima T, 2018 Gastorointestinal Cancers Symposium, 2018/01/18, Without Invitation, San Francisco(USA)
  26. Accuracy of the Effective Atomic Numbers and Theoretical Monochromatic CT Numbers for Contrast Medium with Raw-data Based Dual-energy CT, Kawahara D,Ozawa S,Tanaka S,Yokomachi K,Fujioka C,Ohno Y,Nagata Y, 2018/04/12, Without Invitation, Yokohama, Japan
  27. Clinical Value of Squamous Cell Carcinoma Antigen in Patients with Advanced Cervical Carcinoma Treated by Chemoradiotherapy, Wadasaki K,Nishibuchi I,Imano N,Nagata Y., The 77th Annual Meeting of the Japan Radiological Society, 2018/04/12, Without Invitation, Japan Radiological Society
  28. Demand and Supply of Radiation Oncologists in Future., Nagata Y., The 77th Annual Meeting of the Japan Radiological Society, 2018/04/12, Without Invitation, the Japan Radiological Society
  29. Simulation study of volumetric modulated arc therapy for thoracic esophageal cancer using automated-radiotherapy planning software., Murakami Y,Nagata Y,Kimura T,Nishibuchi I,Nakashima T, 2018 Gastorointestinal Cancers Symposium, 2018/01/18, Without Invitation, San Francisco, USA
  30. A simplified three-isocenter VMAT for craniospinal irradiation., Takahashi I, Imano N, Takeuchi Y, Nishibuchi I, Kimura T, Murakami Y, Nagata Y., ASTRO 2018 (American Society for Therapeutic Radiology and Oncology 60th the Annual Meeting), 2018/10/21, Without Invitation, American Society for Therapeutic Radiology and Oncology, San Antonio, America
  31. A phase II trial of stereotactic body radiation therapy for operable T1N0M0 Non-Small cell lung cancer; Japan clinical oncology group (JCOG0403); Long term follow-up results., Nagata Y, Hiraoka M, Shibata T, Onishi H, Kokubo M, Karasawa K, Shioyama Y, Onimaru R, Kunieda E, Ishikura S., ASTRO 2018 (American Society for Therapeutic Radiology and Oncology 60th the Annual Meeting), 2018/10/21, Without Invitation, American Society for Therapeutic Radiology and Oncology, San Antonio, America
  32. Comparison of stereotactic body radiation therapy combined with or without transcatheter arterial chemoembolization for patients with small hepatocellular carcinoma ineligible for resection or ablation therapies., Kimura T, Doi Y, Aikata H, Imano N, Takeuchi Y, Takahashi I, Nishibuchi I, Katsuta T, Kenjo K, Murakami Y, Awai K, Chayama K, Nagata Y., ASTRO 2018 (American Society for Therapeutic Radiology and Oncology 60th the Annual Meeting), 2018/10/21, Without Invitation, American Society for Therapeutic Radiology and Oncology, San Antonio, America
  33. The efficacy and tolerability of S-1 in the treatment of preoperative chemoradiotherapy for locally advanced rectal cancer., Imano N, Nishibuchi I, Takeuchi Y, Takahashi I, Miki K, Saito A, Kimura T, Murakami Y, Nagata Y., ASTRO 2018 (American Society for Therapeutic Radiology and Oncology 60th the Annual Meeting), 2018/10/21, Without Invitation, American Society for Therapeutic Radiology and Oncology, San Antonio, America
  34. Salvage radiation therapy with elective nodal irradiation for superficial esophageal cancer after incomplete endoscopic resection., Nishibuchi I, Murakami Y, Imano N, Takeuchi Y, Takahashi I, Kimura T, Nagata Y., ASTRO 2018 (American Society for Therapeutic Radiology and Oncology 60th the Annual Meeting), 2018/10/21, Without Invitation, American Society for Therapeutic Radiology and Oncology, San Antonio, America
  35. Vector volume histogram: New method to evaluate deformed organ motion., Miura H, Ozawa S, Doi Y, Kenjo M, Nakao M, Nagata Y., ASTRO 2018 (American Society for Therapeutic Radiology and Oncology 60th the Annual Meeting), 2018/10/21, Without Invitation, American Society for Therapeutic Radiology and Oncology, San Antonio, America
  36. A multicenter single-arm confirmatory trial on hypofractionated whole-breast irradiation after breast-conserving surgery., Kawaguchi Y, Nozaki M, Kagami Y, Shibata T, Nakamura K, Ito Y, Nishimura Y, Saito Y, Nagata Y, Matsumo Y, Akimoto T, Nishimura T, Uno T, Tsujino K, Kataoka M, Kodaira T, Shiraishi K, Inoue K, Isohashi F, Hiraoka M., ASTRO 2018 (American Society for Therapeutic Radiology and Oncology 60th the Annual Meeting), 2018/10/21, Without Invitation, American Society for Therapeutic Radiology and Oncology, San Antonio, America
  37. Study of Interstitial lung disease and acute exacerbation in patients receiving radiation therapy for lunf cancer in Japan., Hagiwara Y, Nakayama Y, Kato T, Saito Y, Hayakawa K, Nakamura N, Kitamoto Y, Takahashi S, Tsujino K, Kubo N, Tamaki Y, Kusumoto M, Iwasawa T, Nagata Y., IASLC 19th World Conference on Lung Cancer, 2018/09/23, Without Invitation, IASLC, Tronto, Canada
  38. Biological dose enhancement using lipiodol in liver SBRT after TACE., Kawahara D, Nakano H, Ozawa S, Saito A, Kimura T, Tsuneda M, Hioki K, Masuda H, Ochi Y, Nakashima T, Ohno Y, Murakami Y, Nagata Y., AAPM 2018(American Association of Physicists in Medicine 60th annual meeting & exhibition), 2018/07/29, Without Invitation, American Association of Physicists in Medicine, Nashville TN, America
  39. Structure and aperture-based robustness estimation for volumetric modulated arc therapy., Mori M, Saito A, Kawahara D, Miki K, Murakami Y, Nakashima T, Okumura T, Nagata Y., AAPM 2018(American Association of Physicists in Medicine 60th annual meeting & exhibition), 2018/07/29, Without Invitation, American Association of Physicists in Medicine, Nashville TN, America
  40. Predictive gamma passing rate based on dose uncertainty for head-and-neck and prostate IMRT., Shiba E, Saito A, Tsuneda M, Furumi M, Yahara K, Ohguri T, Murakami Y, Nishio T, Korogi Y, Nagata Y., AAPM 2018(American Association of Physicists in Medicine 60th annual meeting & exhibition), 2018/07/29, Without Invitation, American Association of Physicists in Medicine, Nashville TN, America
  41. Dose calculation grid for 3D dose verification of VMAT using rotating 2D array of finite-size detectors., Saito A, Nakashima T, Okumura T, Aita M, Hioki K, Kawahara D, Masuda M, Miki K, Mori M, Naito K, Ochi Y, Tsubouchi T, Ohno Y, Nagata Y., AAPM 2018(American Association of Physicists in Medicine 60th annual meeting & exhibition), 2018/07/29, Without Invitation, American Association of Physicists in Medicine, Nashville TN, America
  42. Development of geometrically ideal dose distribution as a reference of treatment planning in VMAT with filtered back projection method., Miki K, Hioki K, Nakashima T, Saito A, Nagata Y., AAPM 2018(American Association of Physicists in Medicine 60th annual meeting & exhibition), 2018/07/29, Without Invitation, American Association of Physicists in Medicine, Nashville TN, America
  43. Automatic contrast medium extraction system using monochromatic CT number., Kawahara D, Ozawa S, Tanaka S, Yokomachi K, Saito A, Higaki T, Fujioka C, Tsuneda M, Mori M, Ohno Y, Nagata Y., AAPM 2018(American Association of Physicists in Medicine 60th annual meeting & exhibition), 2018/07/29, Without Invitation, American Association of Physicists in Medicine, Nashville TN, America
  44. Particle therapy & Immuno-RT, Nagata Y, The National Radiation Oncology Meeting on Advanced Radiation Oncology technologist based on introduction of LINACs in Mongolia, 2018/09/19, Without Invitation, National Cancer Center in Mongolia, Mongolia
  45. SBRT in JAPAN, Nagata Y, HICARE/IAEA International Training Course on Advanced Radiation Therapy (IAEA-RCA Regional Training Course), 2019/02/18, Without Invitation, HICARE/IAEA, Hiroshima, Japan
  46. Current status of SBRT in Japan., Nagata Y., Global Academic Programs 2018 (GAP), 2018/05/15, Without Invitation, Global Academic Programs, Stockholm, Sweden
  47. The Efficacy and Tolerability of S-1 in the Treatment of Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer., Imano N, Murakami Y, Nishibuchi I, Adachi Y, Takeuchi Y, Takahashi I, Kimura T, Nagata Y., The 3rd Meeting of the Federation of Asian Organizations for Radiation Oncology(FARO), 2018/09/06, Without Invitation, the Federation of Asian Organizations for Radiation Oncology(FARO), Bali, Indonesia
  48. A Simplified Three-Isocenter VMAT for Craniospinal Irradiation, Takahashi I, Adachi Y, Imano N, Takeuchi Y, Nishibuchi I, Miki K, Saito, A , Kimura T, Murakami Y, Nagata Y, European Society for Radiotherapy and Oncology meets Asia 2018 (ESTRO), 2018/12/07, Without Invitation, European Society for Radiotherapy and Oncology, Singapore

Awards

  1. 2018/05/20, Honorary Fellowship, American College of Radiology

External Funds

Acceptance Results of Competitive Funds

  1. 2015, 2015
  2. Practical Research for Innovative Cancer Control , 2017/04/01, 2018/03/31
  3. Practical Research for Innovative Cancer Control , 2018/04/01, 2019/03/31

Social Activities

Organizing Academic Conferences, etc.

  1. 2012/07
  2. 2012/07
  3. 2016/06, 2016/06
  4. 2015/08, 2015/08
  5. 2018/08, 2018/08